Navigation Links
China-Biotics, Inc. Reports Record Quarterly Net Sales for the Third quarter of Fiscal Year 2011
Date:2/9/2011

s-14,797,000Interest payable-3,156,035Total current liabilities$

42,558,818$

76,755,753Commitments and contingenciesStockholders' equity:Common stock (par value of $0.0001, 100,000,000 shares authorized, 46,751,004 shares issued and 22,150,200 outstanding as of December 31, 2010 and as of March 31, 2010)$

4,675$

4,675Additional paid-in capital82,769,07482,769,074Retained earnings108,400,68665,441,994Treasury stock at cost (22,370,000 and 24,381,004 shares as of December 31, 2010 and March 31, 2010, respectively)(2,742,072) (2438) Accumulated other comprehensive income8,847,1934,939,830Capital and statutory reserves3,025,7943,025,794Total stockholders' equity$

200,305,350$

153,260,770Total liabilities and stockholders' equity$

242,864,168$

222,692,370CHINA-BIOTICS, INC. AND SUBSIDIARIESUNAUDITED CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS(Amounts expressed in US Dollars)Three months ended
December 31,20102009Net sales$

32,384,645$

23,294,321Cost of sales(11,198,703)(6,780,161)Gross profit$

21,185,942$

16,514,160Operating expenses:Selling expenses$

(3,861,261)$

(4,140,738)General and administrative expenses(3,217,728)(2,260,344)Research and development costs$

(1,856,898)(770,195)Other income/(expenses), net(4,214)3,179Total operating expenses$

(8,940,101)$

(6,397,903)$

12,245,841$

10,100,000Other income and expenses:Changes in the fair value of embedded derivatives$2,847,000 $

2,668,000Exchange gain/(loss)544,773Interest income/(loss)102,38774,438Total other
income/(expenses)$

3,494,160$

2,742,438Income/(loss) before taxes$

15,740,001$

12,858,695Provision for income taxes(2,476,772)(2,379,613)Net income/(loss)$

13,263,229$

10,479,082Earnings/(loss) per share:Basic$

0.59$

0.48Diluted$

0.59$

0.38Sh
'/>"/>

SOURCE China-Biotics, Inc.
Copyright©2010 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5 6 7 8 9 10 11

Related medicine technology :

1. China-Biotics, Inc. Prices $69 Million Public Offering of Common Stock
2. China-Biotics, Inc. Begins Trial Production at New Facility, Affirms 2010 Revenue Guidance
3. China-Biotics, Inc. to Hold 2009 Annual Meeting of Stockholders on March 5, 2010
4. China-Biotics, Inc. Announces US$20 million Share Buyback Program
5. China-Biotics, Inc. Comments on Market Rumors
6. EpiCept Reports Expansion of Clinical Development For Licensed Cancer Compound
7. Spherix Reports Second Quarter Earnings
8. Tapestry Reports Second Quarter 2007 Results
9. Callisto Reports on Second-Quarter 2007 Milestones
10. ImmuneRegen BioSciences Reports Material Transfer Agreement with VaxGen, Inc.
11. Vical Reports Second Quarter 2007 Financial Results, Allowance of Pandemic Influenza IND and Other Advances in Product Development Programs
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/24/2013)... 24, 2013 China Biologic Products, Inc. (Nasdaq: ... integrated plasma-based biopharmaceutical company in China ... from a public announcement issued by Shanghai RAAS Blood ... on Shenzhen Stock Exchange, that on May 21, 2013, ... Chan"), one of the shareholders of the Company, and ...
(Date:5/24/2013)... The potential of the pulmonary ... therapeutic agents has been receiving undeniable attention with the ... promise. The crucial formulation considerations for orally inhaled products ... major role in the efficiency of pulmonary delivery, and ... new formulation techniques and devices in recent years. ...
(Date:5/23/2013)... SAN DIEGO y PARÍS, 24 de ... VOLC ), un destacado desarrollador y fabricante ... para mejorar la diagnosis y tratamiento de la ... resultados preliminares del ensayo ADVISE ( Ad enosine ... tenosis E valuation) II durante la sesión ...
Breaking Medicine Technology:China Biologic Comments on the Proposed Shanghai RAAS Transaction 2China Biologic Comments on the Proposed Shanghai RAAS Transaction 3China Biologic Comments on the Proposed Shanghai RAAS Transaction 4Inhalaltion Drug Delivery: 11-12 September - Berlin, Germany 2Volcano anuncia los resultados preliminares del estudio ADVISE II y su inclusión en el ensayo SYNTAX2 2Volcano anuncia los resultados preliminares del estudio ADVISE II y su inclusión en el ensayo SYNTAX2 3Volcano anuncia los resultados preliminares del estudio ADVISE II y su inclusión en el ensayo SYNTAX2 4Volcano anuncia los resultados preliminares del estudio ADVISE II y su inclusión en el ensayo SYNTAX2 5Volcano anuncia los resultados preliminares del estudio ADVISE II y su inclusión en el ensayo SYNTAX2 6
(Date:5/25/2013)... Texas (PRWEB) May 25, 2013 ... stressful than finals week. Increasingly, they are turning ... stay awake and study. For more on this, ... a drug treatment facility, warns that students who ... finals” are at risk for developing a physical ...
(Date:5/25/2013)... Ayurveda is the traditional medicine ... wisdom of life". While a medical science, its scope enters ... consciousness. Its fundamental philosophy is that disease is the end ... believes that in order to re-establish optimal health, we must ... adopt a life style which brings us back into harmony. ...
(Date:5/25/2013)... Flagstaff, Arizona (PRWEB) May 25, 2013 The ... Rehabilitation Center, their parents, and the B2B staff all came ... While everyone enjoyed an array of Indian Cuisine, the residents ... the company, for helping them on their road to recovery, ... started the Drug and Alcohol center in 2010 after realizing ...
(Date:5/25/2013)... http://www.resource4thepeople.com/defectivedrugs/Actos-Bladder-Cancer-Lawsuit.html , Resource4thePeople is ... of a jury's award of $6.5 million in damages ... the country over allegations that the diabetes drug Actos ... The judge in the case ruled that the man's ... was caused by the medication.** , Bloomberg News in ...
(Date:5/25/2013)... 25, 2013 AdvantaClean of Pikes Peak ... services for a healthy home and business in Colorado ... damage , mold inspections, mold testing, mold removal ... and coil cleaning. , With over 120 offices nationwide, ... industry offering a full suite of services for commercial, ...
Breaking Medicine News(10 mins):Health News:Addiction and Drug Abuse: Study Drug Adderall Abuse Spikes During Finals 2Health News:Ayurveda Education Programs Offered by the California College of Ayurveda Include Panchakarma Certification, Practitioner Courses, and Body Therapy Classes 2Health News:Back2Basics Drug and Alcohol Rehabilitation Center Celebrates Their 3rd Anniversary 2Health News:Alleged Actos Bladder Cancer Lawsuits Update: $6.5 Million Verdict Overturned as Resource4thePeople Attorneys Continue to Accept Cases 2Health News:Alleged Actos Bladder Cancer Lawsuits Update: $6.5 Million Verdict Overturned as Resource4thePeople Attorneys Continue to Accept Cases 3Health News:Alleged Actos Bladder Cancer Lawsuits Update: $6.5 Million Verdict Overturned as Resource4thePeople Attorneys Continue to Accept Cases 4Health News:Grand Opening! AdvantaClean of Pikes Peak is Proud to Announce Water Damage Restoration, Mold Removal and Air Duct Cleaning Services to the Colorado Springs Area 2Health News:Grand Opening! AdvantaClean of Pikes Peak is Proud to Announce Water Damage Restoration, Mold Removal and Air Duct Cleaning Services to the Colorado Springs Area 3Health News:Grand Opening! AdvantaClean of Pikes Peak is Proud to Announce Water Damage Restoration, Mold Removal and Air Duct Cleaning Services to the Colorado Springs Area 4
... Grants New Indication for Bothersome Vaginal Symptom Associated,With ... estrogens) Vaginal Cream 0.5 g has been approved ... a new indication and a new less,frequent twice-weekly ... (painful sexual intercourse) announced Wyeth,Pharmaceuticals, a division of ...
... from patients with lung cancer and examining them under ... utilized to better tailor the chemotherapy treatments to improve ... according to a study presented at the 2008 Chicago ... IASLC and the University of Chicago., Cancer researchers have ...
... tumors of African-American non-small cell lung cancer patients are ... of the epidermal growth factor receptor (EGFR) gene and ... a study presented at the 2008 Chicago Multidisciplinary Symposium ... the University of Chicago., These genetic factors have been ...
... are one milliard of a metre in size are ... materials. There are also significant amounts of nanoparticles in ... their health effects, because only a very small portion ... and safety risks. Nanoparticles have even been dubbed the ...
... http://www.HealthCentral.com ) the leading collection of condition-specific,consumer ... a,broad initiative to sell advertising for any ... partners on a,non-exclusive basis and not require ... party rankings., "We are changing the ...
... those shoppers who,wake up at 4am on Black Friday? Not ... is important not to disturb your circadian rhythm and to ... body,operates better on a good night,s sleep which is why ... the day after Thanksgiving.", SSA retailers nationwide have an ...
Cached Medicine News:Health News:FDA Approves Low-dose Regimen of PREMARIN Vaginal Cream to Treat Moderate to Severe Postmenopausal Dyspareunia - Painful Sexual Intercourse 2Health News:FDA Approves Low-dose Regimen of PREMARIN Vaginal Cream to Treat Moderate to Severe Postmenopausal Dyspareunia - Painful Sexual Intercourse 3Health News:FDA Approves Low-dose Regimen of PREMARIN Vaginal Cream to Treat Moderate to Severe Postmenopausal Dyspareunia - Painful Sexual Intercourse 4Health News:Research demonstrates differing genetic makeup of lung cancer in African-American patients 2Health News:Nanoparticles trigger cell death? 2Health News:HealthCentral Announces New Condition-Specific Ad Service to Offer Marketers the Highest Qualified Audiences 2Health News:Don't Disturb Your Circadian Rhythm This Black Friday 'Sleep In, Nap Later,' says Specialty Sleep Association 2
The K-ASSAY Fibrinogen Control is an assayed quality control material intended for use in monitoring the accuracy and precision of the quantitative determination of fibrinogen....
The K-ASSAY Anti-Streptolysin O Control Set is intended to be used as a consistent test sample of known concentration for monitoring the performance of K-ASSAY immunoturbidimetric assay for quantifyi...
Eppendorf expands its line of benchtop microcentrifuges with the 5418. This easy-to-use microcentrifuge features a certified aerosol-tight rotor and a unique, contoured rotor bowl design to reduce no...
... Directigen EZ Flu A+B test is a ... qualitative detection of influenza A and B ... swabs of symptomatic patients. The Directigen EZ ... such that influenza A viral antigens can ...
Medicine Products: